SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-033331
Filing Date
2020-02-12
Accepted
2020-02-12 16:45:33
Documents
4
Group Members
AMIR NASHATBRIAN CHEEBRYCE YOUNGRENDAVID BARRETTJONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO VI, L.L.C.POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.POLARIS VENTURE PARTNERS VI (AIV), L.P.PVP VI (AIV) FEEDER CORP. HOLDING PARTNERSHIP, L.P.TERRANCE G.

Document Format Files

Seq Description Document Type Size
1 SC 13G d884599dsc13g.htm SC 13G 187976
2 EX-99.A d884599dex99a.htm EX-99.A 13729
3 EX-99.B d884599dex99b.htm EX-99.B 6166
4 EX-99.C d884599dex99c.htm EX-99.C 6088
  Complete submission text file 0001193125-20-033331.txt   215992
Mailing Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners VI, L.P. (Filed by) CIK: 0001493463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Subject) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90858 | Film No.: 20604841
SIC: 2836 Biological Products, (No Diagnostic Substances)